E2F7 is involved in resistance to therapy [35], while EPHA2 is overexpressed in a substantial number of tumors and promotes metastasis by stimulating tumor cell migration, invasion, and angiogenesis [36]. The gene discussed is E2F7; the disease is neoplasm.